This standard specifies technical guidance for the determination of β-glucocerebrosidase activity in human peripheral blood leukocytes using a microplate reader assay. This standard applies to the early diagnosis and preventive treatment of Fabry disease in medical and health institutions.
T/SBX 049-2021 history
2021T/SBX 049-2021 Determination of β-glucocerebrosidase Activity in Human Peripheral Blood Leukocytes by Microplate Reader Assay